Healthcare Nanotechnology (Nanomedicine) Market Analysis By Application (Drug Delivery System, Molecular Diagnostics, Clinical Oncology, Clinical Neurology, Clinical cardiology, Anti-inflammatory, Anti-infective) And Segment Forecasts To 2020
The global market for healthcare nanotechnology is expected to reach USD 196.02 billion by 2020 growing at a CAGR of 12.1%. Increasing susceptibility of patients towards chronic diseases such as cardiovascular, neurological, oncology and respiratory diseases coupled with increasing R&D spending opening new application avenues is expected to drive market growth over the next six years. Other drivers of this market include increasing government and private sector R&D aid and new players entering the market to bridge the gap between supply and demand.
Clinical oncology nanotechnology applications dominated the overall market in 2013, accounting for 35% of total market revenue. Higher efficacy of nanomaterials and the ability of engineered nanoparticles to cross through the blood brain barrier provides platform for groundbreaking innovations through R&D in the field of cancer therapy and serves this market as a high impact rendering driver.
Further key findings from the study suggest:
North America was the largest regional market in 2013, accounting for over 38% of global revenue on account of the extensive investments in research and development of innovative cancer therapies.
Asia Pacific owing to its improving healthcare infrastructure and healthcare R&D spending is expected to grow at the highest CAGR of over 14.0% from 2014 to 2020. Moreover, emerging markets such as China and India hold a large amount of untapped opportunities and are therefore expected to fuel future market growth.
Cardiovascular applications are expected to be the fastest growing segment for this market, owing to the growing global prevalence of cardiovascular diseases.
For the purpose of this study, Grand View Research has segmented the global healthcare nanotechnology market on the basis of fields of application and region:
Clinical oncology nanotechnology applications dominated the overall market in 2013, accounting for 35% of total market revenue. Higher efficacy of nanomaterials and the ability of engineered nanoparticles to cross through the blood brain barrier provides platform for groundbreaking innovations through R&D in the field of cancer therapy and serves this market as a high impact rendering driver.
Further key findings from the study suggest:
North America was the largest regional market in 2013, accounting for over 38% of global revenue on account of the extensive investments in research and development of innovative cancer therapies.
Asia Pacific owing to its improving healthcare infrastructure and healthcare R&D spending is expected to grow at the highest CAGR of over 14.0% from 2014 to 2020. Moreover, emerging markets such as China and India hold a large amount of untapped opportunities and are therefore expected to fuel future market growth.
Cardiovascular applications are expected to be the fastest growing segment for this market, owing to the growing global prevalence of cardiovascular diseases.
For the purpose of this study, Grand View Research has segmented the global healthcare nanotechnology market on the basis of fields of application and region:
- Healthcare Nanotechnology Application Outlook
- Drug delivery Systems
- Molecular Diagnostics
- Clinical Oncology
- Clinical Neurology
- Clinical Cardiology
- Anti-inflammatory and Anti-infective applications
- Healthcare Nanotechnology Regional Outlook
- North America
- Europe
- Asia Pacific
- RoW
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Nanotechnology Healthcare - Industry Summary & Critical Success Factors (CSFs)
CHAPTER 2. NANOTECHNOLOGY HEALTHCARE INDUSTRY OUTLOOK
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Nanotechnology Healthcare Market Dynamics
2.3.1. Market Driver Analysis
2.3.1.1. Growing incidences of chronic severe diseases
2.3.1.2. Technological innovation in medical application of nanotechnology
2.3.1.3. Growing geriatric population base
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Nanotechnology Healthcare market PESTEL Analysis, 2013
CHAPTER 3. NANOTECHNOLOGY HEALTHCARE APPLICATION OUTLOOK
3.1. Drug Delivery System
3.1.1. Global revenue by region, (USD Million), 2012 - 2020
3.2. Molecular Diagnostics
3.2.1. Global revenue by region, (USD Million), 2012 – 2020
3.3. Clinical Oncology
3.3.1. Global revenue by region, (USD Million), 2012 – 2020
3.4. Clinical Neurology
3.4.1. Global revenue by region, (USD Million), 2012 – 2020
3.5. Clinical Cardiology
3.5.1. Global revenue by region, (USD Million), 2012 - 2020
3.6. Anti-Inflammatory and Anti-Infective applications
3.6.1. Global revenue by region, (USD Million), 2012 - 2020
CHAPTER 4. NANOTECHNOLOGY HEALTHCARE REGIONAL OUTLOOK
4.1. North America
4.1.1. Market revenue by application, (USD Million), 2012 – 2020
4.2. Europe
4.2.1. Market revenue by application, (USD Million), 2012 – 2020
4.3. Asia Pacific
4.3.1. Market revenue by application, (USD Million), 2012 – 2020
4.4. RoW
4.4.1. Market revenue by application, (USD Million), 2012 – 2020
CHAPTER 5 COMPETITIVE LANDSCAPE
5.1 Abbott Laboratories.
5.1.1 Company Overview
5.1.2 Financial Performance
5.1.3 Product Benchmarking
5.1.4 Strategic Initiatives
5.2 CombiMatrix Corporation
5.2.1 Company Overview
5.2.2 Financial Performance
5.2.3 Product Benchmarking
5.2.4 Strategic Initiatives
5.3 Celgene Corporation
5.3.1 Company Overview
5.3.2 Financial Performance
5.3.3 Product Benchmarking
5.3.4 Strategic Initiatives
5.4 Mallinckrodt plc.
5.4.1 Company Overview
5.4.2 Financial Performance
5.4.3 Product Benchmarking
5.4.4 Strategic Initiatives
5.5 GE Healthcare
5.5.1 Company Overview
5.5.2 Financial Performance
5.5.3 Product Benchmarking
5.5.4 Strategic Initiatives
5.6 Johnson & Johnson
5.6.1 Company Overview
5.6.2 Financial Performance
5.6.3 Product Benchmarking
5.6.4 Strategic Initiatives
5.7 Merck & Company Inc.
5.7.1 Company Overview
5.7.2 Financial Performance
5.7.3 Product Benchmarking
5.7.4 Strategic Initiatives
5.8 Nanosphere Inc.
5.8.1 Company Overview
5.8.2 Financial Performance
5.8.3 Product Benchmarking
5.8.4 Strategic Initiatives
5.9 Pfizer Inc.
5.9.1 Company Overview
5.9.2 Financial Performance
5.9.3 Product Benchmarking
5.9.4 Strategic Initiatives
5.10 Sigma-Tau Pharmaseuticals Inc.
5.10.1 Company Overview
5.10.2 Financial Performance
5.10.3 Product Benchmarking
5.10.4 Strategic Initiatives
5.11 Teva Pharmaseuticals Industries Ltd.
5.11.1 Company Overview
5.11.2 Financial Performance
5.11.3 Product Benchmarking
5.11.4 Strategic Initiatives
5.12 UCB SA
5.12.1 Company Overview
5.12.2 Financial Performance
5.12.3 Product Benchmarking
5.12.4 Strategic Initiatives
CHAPTER 6. METHODOLOGY AND SCOPE
6.1. Research Methodology
6.2. Research Scope & Assumption
6.3. List of Data Sources
1.1. Nanotechnology Healthcare - Industry Summary & Critical Success Factors (CSFs)
CHAPTER 2. NANOTECHNOLOGY HEALTHCARE INDUSTRY OUTLOOK
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Nanotechnology Healthcare Market Dynamics
2.3.1. Market Driver Analysis
2.3.1.1. Growing incidences of chronic severe diseases
2.3.1.2. Technological innovation in medical application of nanotechnology
2.3.1.3. Growing geriatric population base
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Nanotechnology Healthcare market PESTEL Analysis, 2013
CHAPTER 3. NANOTECHNOLOGY HEALTHCARE APPLICATION OUTLOOK
3.1. Drug Delivery System
3.1.1. Global revenue by region, (USD Million), 2012 - 2020
3.2. Molecular Diagnostics
3.2.1. Global revenue by region, (USD Million), 2012 – 2020
3.3. Clinical Oncology
3.3.1. Global revenue by region, (USD Million), 2012 – 2020
3.4. Clinical Neurology
3.4.1. Global revenue by region, (USD Million), 2012 – 2020
3.5. Clinical Cardiology
3.5.1. Global revenue by region, (USD Million), 2012 - 2020
3.6. Anti-Inflammatory and Anti-Infective applications
3.6.1. Global revenue by region, (USD Million), 2012 - 2020
CHAPTER 4. NANOTECHNOLOGY HEALTHCARE REGIONAL OUTLOOK
4.1. North America
4.1.1. Market revenue by application, (USD Million), 2012 – 2020
4.2. Europe
4.2.1. Market revenue by application, (USD Million), 2012 – 2020
4.3. Asia Pacific
4.3.1. Market revenue by application, (USD Million), 2012 – 2020
4.4. RoW
4.4.1. Market revenue by application, (USD Million), 2012 – 2020
CHAPTER 5 COMPETITIVE LANDSCAPE
5.1 Abbott Laboratories.
5.1.1 Company Overview
5.1.2 Financial Performance
5.1.3 Product Benchmarking
5.1.4 Strategic Initiatives
5.2 CombiMatrix Corporation
5.2.1 Company Overview
5.2.2 Financial Performance
5.2.3 Product Benchmarking
5.2.4 Strategic Initiatives
5.3 Celgene Corporation
5.3.1 Company Overview
5.3.2 Financial Performance
5.3.3 Product Benchmarking
5.3.4 Strategic Initiatives
5.4 Mallinckrodt plc.
5.4.1 Company Overview
5.4.2 Financial Performance
5.4.3 Product Benchmarking
5.4.4 Strategic Initiatives
5.5 GE Healthcare
5.5.1 Company Overview
5.5.2 Financial Performance
5.5.3 Product Benchmarking
5.5.4 Strategic Initiatives
5.6 Johnson & Johnson
5.6.1 Company Overview
5.6.2 Financial Performance
5.6.3 Product Benchmarking
5.6.4 Strategic Initiatives
5.7 Merck & Company Inc.
5.7.1 Company Overview
5.7.2 Financial Performance
5.7.3 Product Benchmarking
5.7.4 Strategic Initiatives
5.8 Nanosphere Inc.
5.8.1 Company Overview
5.8.2 Financial Performance
5.8.3 Product Benchmarking
5.8.4 Strategic Initiatives
5.9 Pfizer Inc.
5.9.1 Company Overview
5.9.2 Financial Performance
5.9.3 Product Benchmarking
5.9.4 Strategic Initiatives
5.10 Sigma-Tau Pharmaseuticals Inc.
5.10.1 Company Overview
5.10.2 Financial Performance
5.10.3 Product Benchmarking
5.10.4 Strategic Initiatives
5.11 Teva Pharmaseuticals Industries Ltd.
5.11.1 Company Overview
5.11.2 Financial Performance
5.11.3 Product Benchmarking
5.11.4 Strategic Initiatives
5.12 UCB SA
5.12.1 Company Overview
5.12.2 Financial Performance
5.12.3 Product Benchmarking
5.12.4 Strategic Initiatives
CHAPTER 6. METHODOLOGY AND SCOPE
6.1. Research Methodology
6.2. Research Scope & Assumption
6.3. List of Data Sources
LIST OF TABLES
Nanotechnology Healthcare – Industry Summary & Critical Success Factors (CSFs)
Global Nanotechnology Healthcare market share (USD Million), 2012 - 2020
Global Nanotechnology Healthcare market by region (USD Million), 2012 – 2020
Global Nanotechnology Healthcare market by application (USD Million), 2012 – 2020
Global Drug Delivery Systems revenue by region, (USD Million), 2012 – 2020
Global Molecular Diagnostics revenue by region, (USD Million), 2012 – 2020
Global Clinical Oncology revenue by region, (USD Million), 2012 – 2020
Global Clinical Neurology revenue by region, (USD Million), 2012 – 2020
Global Clinical Cardiology revenue by region, (USD Million), 2012 – 2020
Global Anti-inflammatory and Anti-infective application revenue by region, (USD Million), 2012 – 2020
North America Nanotechnology Healthcare market by application (USD Million), 2012 – 2020
Europe Nanotechnology Healthcare market by application (USD Million), 2012 – 2020
Asia Pacific Nanotechnology Healthcare market by application (USD Million), 2012 – 2020
RoW Nanotechnology Healthcare market by application (USD Million), 2012 – 2020
Nanotechnology Healthcare – Industry Summary & Critical Success Factors (CSFs)
Global Nanotechnology Healthcare market share (USD Million), 2012 - 2020
Global Nanotechnology Healthcare market by region (USD Million), 2012 – 2020
Global Nanotechnology Healthcare market by application (USD Million), 2012 – 2020
Global Drug Delivery Systems revenue by region, (USD Million), 2012 – 2020
Global Molecular Diagnostics revenue by region, (USD Million), 2012 – 2020
Global Clinical Oncology revenue by region, (USD Million), 2012 – 2020
Global Clinical Neurology revenue by region, (USD Million), 2012 – 2020
Global Clinical Cardiology revenue by region, (USD Million), 2012 – 2020
Global Anti-inflammatory and Anti-infective application revenue by region, (USD Million), 2012 – 2020
North America Nanotechnology Healthcare market by application (USD Million), 2012 – 2020
Europe Nanotechnology Healthcare market by application (USD Million), 2012 – 2020
Asia Pacific Nanotechnology Healthcare market by application (USD Million), 2012 – 2020
RoW Nanotechnology Healthcare market by application (USD Million), 2012 – 2020
LIST OF FIGURES
Nanotechnology Healthcare Market Segmentation
Global Nanotechnology Healthcare market (USD Million), 2012 - 2020
Nanotechnology Healthcare value chain analysis
Nanotechnology Healthcare market dynamics
Nanotechnology Healthcare - Company market share analysis, 2013
Key Opportunities Prioritized
Industry Analysis - Porter's
Nanotechnology Healthcare PESTEL Analysis, 2013
Nanotechnology Healthcare market share by application, 2012 & 2020
Nanotechnology Healthcare market share by region, 2012 & 2020
Global Drug Delivery Systems revenue by region, (USD Million), 2012 – 2020
Global Molecular Diagnostics revenue by region, (USD Million), 2012 – 2020
Global Clinical Oncology revenue by region, (USD Million), 2012 – 2020
Global Clinical Neurology revenue by region, (USD Million), 2012 – 2020
Global Clinical Cardiology revenue by region, (USD Million), 2012 – 2020
Global Anti-inflammatory and Anti-infective application revenue by region, (USD Million), 2012 – 2020
North America Nanotechnology Healthcare market, by application (USD Million), 2012 – 2020
Europe Nanotechnology Healthcare market, by application(USD Million), 2012 – 2020
Asia Pacific Nanotechnology Healthcare market, by application(USD Million), 2012 – 2020
RoW Nanotechnology Healthcare market, by application(USD Million), 2012 – 2020
Nanotechnology Healthcare Market Segmentation
Global Nanotechnology Healthcare market (USD Million), 2012 - 2020
Nanotechnology Healthcare value chain analysis
Nanotechnology Healthcare market dynamics
Nanotechnology Healthcare - Company market share analysis, 2013
Key Opportunities Prioritized
Industry Analysis - Porter's
Nanotechnology Healthcare PESTEL Analysis, 2013
Nanotechnology Healthcare market share by application, 2012 & 2020
Nanotechnology Healthcare market share by region, 2012 & 2020
Global Drug Delivery Systems revenue by region, (USD Million), 2012 – 2020
Global Molecular Diagnostics revenue by region, (USD Million), 2012 – 2020
Global Clinical Oncology revenue by region, (USD Million), 2012 – 2020
Global Clinical Neurology revenue by region, (USD Million), 2012 – 2020
Global Clinical Cardiology revenue by region, (USD Million), 2012 – 2020
Global Anti-inflammatory and Anti-infective application revenue by region, (USD Million), 2012 – 2020
North America Nanotechnology Healthcare market, by application (USD Million), 2012 – 2020
Europe Nanotechnology Healthcare market, by application(USD Million), 2012 – 2020
Asia Pacific Nanotechnology Healthcare market, by application(USD Million), 2012 – 2020
RoW Nanotechnology Healthcare market, by application(USD Million), 2012 – 2020
